Your browser doesn't support javascript.
loading
Cellular and Humoral Immune Responses and Breakthrough Infections After Two Doses of BNT162b Vaccine in Healthcare Workers (HW) 180 Days After the Second Vaccine Dose.
Mangia, Alessandra; Serra, Nicola; Cocomazzi, Giovanna; Giambra, Vincenzo; Antinucci, Stefano; Maiorana, Alberto; Giuliani, Francesco; Montomoli, Emanuele; Cantaloni, Paolo; Manenti, Alessandro; Piazzolla, Valeria.
Afiliación
  • Mangia A; Liver Unit, Fondazione IRCCS "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Italy.
  • Serra N; Department of Public Health, University "Federico II", Naples, Italy.
  • Cocomazzi G; Liver Unit, Fondazione IRCCS "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Italy.
  • Giambra V; Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapies (ISBReMIT), San Giovanni Rotondo, Italy.
  • Antinucci S; Allergy Diagnostic Section Euroimmun, Italy Fondazione "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Italy.
  • Maiorana A; GSSL Unit, Fondazione "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Italy.
  • Giuliani F; ICT Innovation and Research Unit, Fondazione IRCCS "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Italy.
  • Montomoli E; Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
  • Cantaloni P; VisMederi Srl, Siena, Italy.
  • Manenti A; VisMederi Srl, Siena, Italy.
  • Piazzolla V; VisMederi Srl, Siena, Italy.
Front Public Health ; 10: 847384, 2022.
Article en En | MEDLINE | ID: mdl-35433614
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Front Public Health Año: 2022 Tipo del documento: Article País de afiliación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Front Public Health Año: 2022 Tipo del documento: Article País de afiliación: Italia